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Abstract In biomedical research, boosting-based regression approaches have gained1
much attention in the last decade. Their intrinsic variable selection procedure and2
ability to shrink the estimates of the regression coefficients toward 0 make these tech-3
niques appropriate to fit prediction models in the case of high-dimensional data, e.g.4
gene expressions. Their prediction performance, however, highly depends on specific5
tuning parameters, in particular on the number of boosting iterations to perform. This6
crucial parameter is usually selected via cross-validation. The cross-validation proce-7
dure may highly depend on a completely random component, namely the considered8
fold partition. We empirically study how much this randomness affects the results of9
the boosting techniques, in terms of selected predictors and prediction ability of the10
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related models. We use four publicly available data sets related to four different dis-11
eases. In these studies, the goal is to predict survival end-points when a large number12
of continuous candidate predictors are available. We focus on two well known boost-13
ing approaches implemented in the R-packages CoxBoost and mboost, assuming the14
validity of the proportional hazards assumption and the linearity of the effects of the15
predictors. We show that the variability in selected predictors and prediction ability16
of the model is reduced by averaging over several repetitions of cross-validation in17
the selection of the tuning parameters.18
Keywords Boosting · Cross-validation · Parameter tuning · High dimensional data ·19
Survival analysis20
1 Introduction21
Boosting-based regression approaches have gained a lot of attention in the last decade,22
showing both interesting theoretical properties (Bühlmann and Yu 2003; Bühlmann23
2006; Tutz and Binder 2006) and yielding good empirical results in terms of prediction24
accuracy, including applications to prediction with high-dimensional data (Mayr et al.25
2014a). In this paper we focus specifically on two boosting approaches that are based26
on a solid theoretical framework, implemented in user-friendly software and able to27
efficiently cope with high-dimensional data and handle censored survival end-points:28
the model-based boosting approach (Bühlmann and Yu 2003), implemented in the R29
package mboost (Hothorn et al. 2015); and the likelihood-based boosting approach30
(Tutz and Binder 2006) adapted to survival end-points by Binder and Schumacher31
(2008a) and implemented in the R package CoxBoost (Binder 2013).32
In our analyses we focus on prediction models for time-to-event outcomes. This33
kind of application, despite being extremely common in biomedical practice, has not34
been well investigated in statistical literature in the case when a large number of can-35
didate predictors, such as gene expressions, are available. In this context, boosting36
techniques can play an important role. They have, indeed, two important character-37
istics which are essential in providing a good prediction model when the number of38
the predictors exceeds the sample size: the ability to shrink the parameter estimates39
toward 0, and the identification of the relevant predictors (variable selection). The lat-40
ter is performed by allowing only a moderate number of parameters to have non-zero41
values. These two properties suggest the existence of a relationship between boosting42
techniques and methods based on penalized regression. Works which have investigated43
this connection, mainly focusing on the similarities between L2-boosting and lasso,44
are Hastie et al. (2001), Efron et al. (2004) and Bühlmann and Hothorn (2007).45
Another common characteristic of the boosting and the penalized regression tech-46
niques is the presence of one or more tuning parameters. In particular, as boosting47
is an iterative method in which a weak learner is sequentially applied to a suitable48
modification of the data, the most critical parameter to set is the number of iterations49
(boosting steps). Its choice greatly impacts the number of involved predictors and the50
complexity of the resulting prediction model. Despite the importance of this param-51
eter, literature on its choice is scarce. The R packages mboost and CoxBoost exploit52
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cross-validation-based procedures. In particular, when working with proportional haz-53
ards models, both packages implement the cross-validated partial log-likelihood by54
Verweij and Houwelingen (1993). The package mboost also offers a different pro-55
cedure, based on the Akaike information criterion: introduced by Bühlmann (2006)56
and investigated in the survival analysis context by Hothorn et al. (2006), its use in57
practice is actually discouraged due to its tendency to overshoot the optimal value58
(Hofner et al. 2014). This tendency is primarily due to the systematic underestimation59
of the true degrees of freedom in component-wise boosting algorithms (Mayr et al.60
2012). An advantage of AIC-based stopping criteria is that they can be made totally61
data-driven, avoiding the necessity of pre-specifying a range of values to search for62
the optimum. The works of Chang et al. (2010) and, especially, Mayr et al. (2012)63
focus on this approach, with the latter adjusting for the underestimation of the degrees64
of freedom using a re-sampling method, at the expense of computation time.65
However, the aforementioned approaches are not really well-known and cross-66
validation is by far the most popular procedure used in practice to choose the number67
of boosting steps. Unfortunately, cross-validation is often implemented without tak-68
ing into account its possible drawbacks and the effect that it can have on the tuning69
procedure. An important problem of cross-validation and related approaches is the70
high variability of the results (Boulesteix et al. 2013): the output may be completely71
different for two different random partitions into the K folds used in the proce-72
dure, in the sense that different numbers of boosting steps are identified as optimal73
depending on the considered random partition. As a consequence, the final predic-74
tion model—fit using the selected number of boosting steps—may greatly depend75
on a completely random component, namely the considered partition into the K76
folds.77
In this paper we address the issue of the choice of the number of boosting steps from78
an empirical perspective. In particular, we specifically address three questions related79
to the variability of cross-validation-based results: (i) how much does the prediction80
accuracy of the final prediction model depend on the random CV partition used for81
the choice of the number of boosting steps? (ii) how much do the set of selected82
predictors depend on the random CV partition used for the choice of the number of83
boosting steps? (iii) to what extent can this variability be reduced through adapting84
the cross-validation tuning procedure by averaging over several random partitions85
into K folds? Despite the focus on the prediction of censored survival end-points from86
high-dimensional data, most conclusions are generalizable to other types of end-points87
and/or other types of predictors.88
This paper is structured as follows. Section 2 gives an introduction to the two89
considered boosting methods, cross-validation for tuning and the evaluation of survival90
prediction models using the Brier score. The first empirical study based on four high-91
dimensional gene expression data sets, each consisting of both learning and test sets, is92
presented in Sect. 3. The effect of considering several partitions in the cross-validation93
procedure is shown in the second empirical study (Sect. 4). Finally, Sect. 5 contains94
some conclusions. A simulation study in which we investigate the role of correlation95
between covariates with respect to the number of boosting steps and the prediction is96
available in the Supplementary Material. R-codes used for this paper are available in97
the Electronic Supplementary Material.98
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2 Methods99
The general idea of a boosting procedure is to repeatedly fit a weak estimator to the100
data in order to minimize a loss function. Here we focus on the implementation to sur-101
vival data of the model-based boosting and the likelihood-based boosting approaches.102
Both depend on two tuning parameters: a penalty parameter, whose choice is usually103
hardly influential, and the number of boosting steps, mstop, which, on the contrary,104
greatly affects the performance of the procedure and, consequently, the behavior of105
the resulting prediction model. In this section, we briefly review the two boosting algo-106
rithms, sketch how to apply the cross-validation technique in order to select mstop, and107
provide some information on the Brier score, the measure of prediction ability that108
we use in the paper. For a more complete review on boosting, please see Mayr et al.109
(2014b)110
2.1 Model-based boosting111
Model-based boosting is a direct implementation of the gradient boosting idea112
described in the seminal paper of Friedman (2001), which provides a statistical view113
of the boosting technique introduced by Freund and Schapire (1996) in the machine114
learning literature. In the Friedman paper, boosting is characterized as a gradient115
descent algorithm, where in each iteration a base learner is fit to the negative gradient116
of a loss function. Here we focus on its adaption to survival data which fit the Cox117
model assumptions, as implemented in the package mboost within the function glm-118
boost with argument family=CoxPH(). In particular, this version uses the negative119
partial likelihood as the loss function and the ordinary least squares estimator as the120
base-learner. The derivation of the negative gradient vector was firstly provided in121
Ridgeway (1999). Based on the mboost function, other implementations using spe-122
cific weights (Hothorn et al. 2006) or considering non-linear effect for the predictors123
(e.g., Schmid and Hothorn 2008) are available through the mboost function, but are124
not considered here.125
The package mboost implements the component-wise boosting version, the use126
of which is often motivated by the challenges typical of high-dimensional data. This127
procedure consists of updating the vector of regression coefficient estimates only one128
dimension at a time. At each step, for all the vector components, a possible update129
is computed by fitting a least squares estimator on the gradient vector. Among all130
possible updates, the one which decreases the loss function the most is selected,131
and it is added, suitably multiplied by a penalty parameter, to the related regression132
coefficient estimate. This updating procedure ends when the pre-specified number of133
boosting steps mstop is reached. It is worth stressing the crucial role of this parameter: if134
it is too small the estimates of the regression coefficients may be insufficiently refined,135
leading to a prediction model unable to explain the outcome variability; if it is too136
large, the final model risks being too complex and overfitting the learning data. The137
number of boosting steps highly affects the variable selection property of the boosting138
procedure as well: the chance of including a predictor in the model, indeed, increases139
with the number of iterations. Therefore, if the number of steps performed is too small,140
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a relevant predictor may be excluded from the model. While if it is too large, irrelevant141
predictors may be included, with high risk, especially in the high-dimensional data142
context of overfitting. In contrast, the choice of the penalty term is unimportant, and,143
in our analyses, we keep the default value (0.10, see, e.g., Bühlmann and Hothorn144
2007).145
2.2 Likelihood-based boosting146
The second algorithm that we consider is the adaptation to survival data of likelihood-147
based boosting (Tutz and Binder 2006), introduced by Binder and Schumacher (2008a)148
and implemented in the R package CoxBoost. This algorithm uses a penalized version149
of the negative partial log-likelihood as the loss function, which it minimizes by repeat-150
edly fitting a first order approximation of the ridge estimator. In the component-wise151
version used in this paper, only one regression coefficient per iteration is updated,152
although the R package offers the chance to update more at each step (Binder and153
Schumacher 2008a). In practice, at each step all possible updates (one for each regres-154
sion coefficient) are computed, and then the most relevant—namely that which, once155
plugged into the loss function, leads to the smallest value—is selected. This “best”156
update is incorporated in an offset term, which is simply the linear predictor obtained157
in the previous boosting step. Again, the total number of boosting steps performed158
is highly relevant in determining the behavior of the resulting prediction model, and159
a good choice of this tuning parameter is again crucial. As with the model-based160
boosting technique, there is a second tuning parameter to consider, the penalty term.161
In this case, it is directly applied to the partial log-likelihood through the L2 norm162
which characterizes the ridge regression. The penalty term is usually selected through163
the rough method implemented in the function optimCoxBoostPenalty of the package164
CoxBoost. In this paper: (i) to have a more robust result, we repeat the procedure 100165
times and take the median value; (ii) since we will consider several kinds of cross-166
validation (leave-one-out, 3-, 5-, 10 and 20-fold), we repeat the procedure for each167
kind of cross-validation and select the median value among the 5 penalty parameters.168
The use of a single penalty term for all kinds of cross-validation procedure assures the169
comparability of their results in terms of the number of boosting steps. Obviously this170
procedure does not optimize the value of the penalty parameter, but it quickly provides171
a term with a reasonable magnitude: as with model-based boosting, the choice of the172
penalty parameter is not crucial. The original paper only claims that a “large enough”173
value is necessary (Binder and Schumacher 2008a).174
2.3 Choice of the tuning parameter based on cross-validation175
The number of boosting steps is highly relevant in both boosting procedures consid-176
ered. We stated in the introduction that the usual way to compute its value is through177
cross-validation (CV). The general idea of CV is to mimic the presence of a learning178
and a test set by splitting the available data set D into K disjoint and approximately179
equal-sized subsets D1, . . . , DK . Each fold of this split is then separately used as a180
test set to evaluate the behavior of a model fit on the other K − 1 folds.181
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In the R implementation of the two boosting procedures analyzed, the evaluation is182
made in terms of the cross-validated partial log-likelihood introduced by Verweij and183
Houwelingen (1993),184
cvpl(m) =
K∑
k=1
(
pl
(
βˆ
(−Dk )
m
)
− pl(−Dk )
(
βˆ
(−Dk )
m
))
, (1)185
where pl(·) denotes the complete partial log-likelihood, pl(−Dk )(·) the partial log-186
likelihood computed without the observations contained in the k-th fold and βˆ(−Dk )m187
denotes the vector of the regression coefficient estimates computed using the same188
subset (D without observations in Dk). Note that the value of the first term on the right189
hand side of Eq. 1 increases with increasing proximity of βˆ(−Dk )m to the maximum190
likelihood estimate (mle). The second term, instead, penalizes for possible over-fitting:191
it is computed on the data used to obtain βˆ(−Dk )m , and therefore it decreases the value192
of cvpl(m) as much as βˆ(−Dk )m explains too much the data variability.193
The cross-validated partial log-likelihood is used to estimate the optimal number of194
boosting steps. The estimates of the regression coefficients, indeed, depends on m, as195
highlighted by the subscripts in Eq. 1. The optimal value mstop, therefore, is obtained196
by maximizing over m the cross-validated partial log-likelihood.197
2.4 Brier score and integrated Brier score198
The Brier score is a quadratic score rule originally developed to measure the accuracy199
of weather forecasts (Brier 1950) and adapted to the context of survival analysis200
by Graf et al. (1999). In this context, the Brier score is able to measure both the201
discriminative ability and the calibration of a model, in contrast, e.g., with the widely202
used concordance index, which is only able to evaluate the former property (De Bin203
et al. 2014a). The Brier score is based on the predicted survival probability Sˆi (t), that,204
ideally, at time t should be 1 if the subject i is alive, 0 otherwise (Schumacher et al.205
2007). If I (Ti > t) indicates whether the observation i is or is not alive at time t , the206
Brier score can be estimated as207
BˆS(t) = 1
n
n∑
i=1
Wˆi (t)
(
I (Ti > t) − Sˆi (t)
)2
208
where n is the number of the observations in the test data set and Wˆi (t) are weights209
introduced in order to deal with censored observations (for further details, see Gerds210
and Schumacher 2006; Mogensen et al. 2012). Please note that the survival probability211
estimation Sˆ is computed using the test set, but is calculated based on the model212
determined using the learning set.213
When plotted with respect to time, the Brier score leads to the so-called prediction214
error curves, which can be used to graphically investigate the behavior of the predictive215
model. Alternatively, we can summarize the information in a single value, called the216
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“integrated Brier score”, by integrating the Brier score with respect to the time. The217
integrated Brier score corresponds to the measure of the area under the prediction error218
curves,219
ˆI BS =
∫ T
0
BˆS(t) dt,220
where T is the value up to which the integral is considered. In our study, we select T221
as the largest time value in the test set.222
3 Empirical study223
3.1 Data224
In our analyses, we consider four publicly available medical data sets with survival225
outcome and information on gene expression of patients (see Table 1). Each of these226
data sets consists of a learning set, using which we compute the optimal number of227
boosting steps and fit the model, and a test set, for which we compute the integrated228
Brier score. It is particularly important to keep the learning and test data totally separate229
in order to have a reliable evaluation of the prediction abilities of the resulting models.230
In all analyses, we assume that the covariate effects are linear and that the proportional231
hazards assumption holds.232
Breast cancer data This data set is from a prospective multicenter study conducted233
by Hatzis et al. (2011) to develop genomic predictors for neoadjuvant chemotherapy.234
It involves patients with newly diagnosed ERBB2 (HER2 or HER2/neu)-negative235
breast cancer, for which information is provided on the (possibly censored) distant236
relapse-free survival time and the gene expressions of 22283 probe sets, which is237
obtained through the Affymetrix U133A GeneChip. The data set consists of a learning238
set, containing information on patients who had their biopsy between June 2000 and239
December 2006, and an independent test set, whose patients had their biopsy between240
April 2002 and January 2009. Specifically, we use the observations considered in De241
Bin et al. (2014b): the sample sizes are 282 patients (with 57 events) and 182 patients242
Table 1 The four data sets used in our empirical study
Disease Sample size (events) Number of
predictors
Reference
Learning set Test set
Breast cancer 282 (57) 182 (41) 22,283 Hatzis et al. (2011)
Diffuse large B-cell
lymphoma
149 (79) 73 (48) 7399 Rosenwald et al. (2002)
Acute myeloid
leukemia
163 (103) 79 (32) 44,754 Metzeler et al. (2008)
Neuroblastoma 242 (40) 120 (35) 9978 Oberthuer et al. (2008)
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(41 events) for the learning and test sets, respectively. The data are publicly available243
from the Gene Expression Omnibus, reference GSE25066.244
Diffuse large B-cell lymphoma The second data set is from the study of Rosenwald245
et al. (2002) on patients with diffuse large B-cell lymphoma. It contains 7399 gene-246
expression measurements from 240 patients who had no previous history of lymphoma,247
divided in a learning set (160 patients) and a test set (80 patients). The outcome of248
interest is the overall survival time. In our paper we use the data set as pre-processed249
by Bøvelstad et al. (2009), which contains the information of only the 222 patients250
for which the International Prognostic Index is also available. However, we did not251
consider this predictor in our analysis. As a result of this restriction, the learning and252
test sets contains 149 and 73 patients, respectively. Due to the presence of censored253
data, the effective sample sizes are 79 (learning set) and 48 (test set).254
Acute myeloid leukemia data The third data set contains information on patients with255
acute myeloid leukemia enrolled between 1999 and 2003 (learning set) or in 2004 (test256
set) in a multicenter trial of the German AML Cooperative Group (Metzeler et al. 2008).257
The outcome of interest is the overall survival, defined as the time between study entry258
and death from any cause. The learning set contains 163 patients, of which 103 died.259
The data consist of the gene-expression measurements of 44754 probe sets, obtained260
using the Affymetrix HG-U133 A&B microarray. For the 79 patients belonging to261
the test set (32 events), instead, the gene expressions were derived using Affymetrix262
HG-U133 plus 2.0 microarray. The data is publicly available from Gene Expression263
Omnibus, reference GSE12417.264
Neuroblastoma data The last data set contains information on patients with neurob-265
lastoma studied by Oberthuer et al. (2008). The original learning set consists of 256266
patients recruited between 1989 and 2004 for the German Neuroblastoma Trial NB90-267
NB2004 for which the overall survival time and the gene expressions of 9978 probe268
sets are available. The test set consists of 120 patients with the same disease, but col-269
lected in several countries (29 in Germany, 26 in the US, 26 in France, 12 in Spain,270
11 in Italy, 6 in Belgium, 5 in the UK and 5 in Israel), for which the same outcome271
and probe sets were measured. In our study, we did not directly use the data from272
the original study (available from the ArrayExpress database, accession number E-273
MTAB-16), but those pre-processed by Bøvelstad et al. (2009), in which 14 patients274
are excluded due to missing data. Since it was not possible to recover the original split275
into learning and test sets, here we randomly split the whole data set into a learning276
set of 242 patients (40 events) and a test set of 120 patients (35 observations), which277
are the sample sizes used by Bøvelstad et al. (2009).278
3.2 Study design279
The main focus of our first study is the cross-validation-based choice of the optimal280
number of boosting steps in model-based and likelihood-based boosting. We consider281
values between 0 and 200. The lower limit leads to the null model, while the upper limit282
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has been arbitrarily chosen as “sufficiently large” (namely, twice the default in both283
mboost and CoxBoost). We investigate how the variability caused by randomness due284
to the CV fold-split affects the results of the boosting procedures in terms of number285
of iterations performed, selected predictors and prediction ability of the models.286
In our analysis, for both boosting techniques we replicate the following 2000 times:287
– we apply the 3-, 5-, 10- and 20-fold CV procedures to compute the optimal number288
of boosting steps, using only the observations from the learning set;289
– we fit a prediction model by applying the boosting technique to the learning set,290
using the tuning parameter obtained in the previous point;291
– we note the number of predictors selected in the model;292
– we evaluate the prediction ability of the model by estimating the integrated Brier293
score on the test set.294
In addition, we collect the same information (number of boosting steps, number of295
selected predictors, integrated Brier score) when using leave-one-out CV: since this296
procedure is deterministic, this operation is performed only once.297
3.3 Results298
3.3.1 Number of boosting steps299
The first goal of this empirical study is to evaluate how the optimal number of boosting300
steps (mstop) is influenced by the different random splits—learning and test sets—of301
the cross-validation procedure. Figure 1 shows the distribution of the values obtained302
over 2000 iterations for each data set, using the CV procedures implemented both in303
mboost and in CoxBoost. This and the following figures contain information on results304
of regular CV as well as information on results of repeated CV. The repeated CV is305
discussed in Sect. 4. For now we focus on the white boxplots in Fig. 1, which show306
results for the regular cross-validation. Regardless of the boosting technique chosen,307
the variability of mstop is very large, with values that range from 0 (minimum) to308
200, the upper limit that we considered in our experiment. In particular, this means309
that, using the same data, we can obtain completely different results simply due to310
the particular fold-split used. The four considered example data sets suggest that311
this result may be partially mitigated by a large sample size (although this different312
behavior may of course also be simply due to random variations): we notice that in the313
acute myeloid leukemia example, in which we have 103 events, we experience less314
variability (see Fig. 1, third row) than in the other data sets, especially when applying315
mboost. Nevertheless, it is worth noting that the sample sizes and, more in general,316
the characteristics of all our data sets, are typical of biomedical studies and therefore317
in practical situations we may experience this large variability in the choice of mstop.318
As expected, the variability decreases with an increase in the number of folds because319
increasing the number of folds means approaching to (the completely deterministic)320
leave-one-out CV. Leave-one-out CV produces extreme numbers of steps in mboost321
for all data sets except the Neuroblastoma data set and for CoxBoost in the DLBCL322
data set. All extreme numbers of steps for leave-one-out CV are higher than most or323
all numbers of steps computed by other cross-validation procedures. This suggests324
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Fig. 1 Number of boosting steps (mstop) selected in the 2000 iterations (except leave-one out CV) computed
using different CV folds in the four data sets with both CoxBoost (left) and mboost (right). The color defines
the type of CV. White stands for normal, gray for repeated CV
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that leave-one-out CV leads to models that are more likely to overfit the data in these325
cases.326
Note that in our study the number of boosting steps is allowed to vary from 0327
to 200. In some cases (see, e.g., the results for the breast cancer data set, Fig. 1,328
first row) the upper limit is reached, meaning that the results could be even more329
extreme with a larger maximum number of boosting steps. Given the relevant increase330
in computational time and computer memory necessary to consider a higher upper331
limit, we think that a value of 200 is fairly reasonable and sufficient to demonstrate332
the problem of variability induced due to the random CV splits.333
3.3.2 Selected predictors334
The high variability in the choice of mstop is not a problem itself, but it may substantially335
affect the model building process and consequently the properties of the prediction336
model. In Fig. 2 we report the number of predictors selected in each of the replications337
of our experiment for the model-based (mboost) and the likelihood-based (CoxBoost)338
boosting procedures, respectively. The downward facing triangles indicate the min-339
imum number of predictors selected, i.e. the number of predictors always selected.340
The upward facing triangles indicate the maximum number of predictors selected,341
i.e. the number of predictors selected at least once. For a more precise visualization342
of the number of predictors always selected and the number of predictors selected at343
least once, see Figures 6 and 7 in the Supplementary Material. The Supplementary344
materials also contain the complete tables of the selected predictors, including the345
information on the number of times they are selected (Tables 2–5 in the Supplemen-346
tary Material). Note that the number of predictors selected at least once, the number of347
predictors always selected and the mean number of predictors selected, is equivalent348
for leave-one-out CV because it is deterministic and was only computed once.349
Again, we first focus on the regular CV and ignore the results of the repeated CV350
for now. The different values of mstop, as determined by the random fold-splits in351
the cross-validation procedure, greatly influence the prediction models in terms of352
selected predictors. In particular, extremely low values of mstop prevent the boosting353
technique from including many predictors in the model: as a consequence, very few354
predictors are selected in all 2000 replications performed in our study. On the other355
hand, high values of mstop can result either in higher values for the estimates of a few356
predictors or in a high number of selected predictors: in our examples the latter seems357
to happen, as shown by the relatively large number of predictors selected at least once.358
Note that a boosting model always contains all predictors of a scarcer model (with359
fewer boosting steps), i.e. the predictors selected in the beginning always stay in the360
model.361
The (relatively) greater stability in the choice of mstop induced by a larger number362
of folds in the cross-validation procedure results both in an increase in the number of363
predictors selected in all replications and a decrease in the predictors selected at least364
once. This is least strong in the application of the breast cancer data: both for mboost365
and CoxBoost, the variability of mstop slightly decreases with increasing number of366
folds but not as strong as in the other applications (see Fig. 1, first row). This results367
in a less evident stabilization in the predictors selected. For example using CoxBoost368
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Fig. 2 Number of predictors selected in 2000 iterations computed using different CV folds in the four
data sets with both CoxBoost (left) and mboost (right). The color defines the type of CV. White stands for
normal, gray for repeated CV. The triangles indicate the minimum and maximum number of predictors
selected (color figure online)
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the number of predictors always included is 0 for the 3-fold CV, 1 for the 5-fold,369
3 for the 10-fold and 2 for the 20-fold for the breast cancer data, whereas for the370
acute myeloid leukemia data it is 3 for the 3-fold, 3 for the 5-fold, 9 for the 10-fold371
and 10 for the 20-fold CV. The number of predictors selected at least once is always372
45 for the breast cancer data but goes down from 43 (3-fold) to 21 (20-fold) for the373
acute myeloid leukemia data. There is no tendency of the median number of selected374
predictors over data sets. For the DLBCL and AML data it increases with increasing375
number of folds. For the Breast cancer and Neuroblastoma data it decreases with376
increasing number of folds for CoxBoost and does not show a clear tendency for377
mboost.378
Leave-one-out CV in general tends to favor more complex models, which are more379
likely to overfit the learning data. Figure 2 supports that in mboost for all data sets380
except the neuroblastoma data set. For CoxBoost the number of predictors selected is381
particularly high for the DLBCL data. So essentially all examples that show extremely382
high values for mstop also show many predictors included in the model.383
Finally, we note that in all the four data sets the rank of the predictors based on384
their inclusion frequencies is slightly different between mboost and CoxBoost (see385
Tables 2–5 in the Supplementary Material). This is a consequence of the differences386
in the learning path for the two boosting techniques (for further details, see De Bin387
2016).388
3.3.3 Connection between the number of boosting steps and the number of selected389
predictors390
Throughout the paper, we stressed the influence of the number of boosting steps on the391
model sparsity. To better understand this statement, we plot in Fig. 3 all values of mstop392
obtained in all iterations against the number of predictors included in the corresponding393
models. Given a certain mstop the model is deterministic and hence a differentiation394
between different types of CV is not needed here. We note that models are less sparse395
as the value of the optimal number of boosting steps increases, resulting in a non-396
decreasing function. The steps in the curve correspond to those iterations in which397
the boosting algorithm includes a new predictor into the model. When the algorithm398
updates the regression coefficient of a previously selected predictor, instead, the curve399
remains flat. Please note that the boosting learning path is deterministic. Therefore,400
once we know the number of boosting steps (and the penalty factor), we can determine401
uniquely the fitted model.402
Figure 3 shows once again how important a stable selection of the number of403
boosting steps is. Extremely large values may result in extremely complex models and404
the other way around for extremely small mstop, with obvious implications in terms405
of interpretation and prediction accuracy.406
We note that the slopes of the curves for mboost and CoxBoost are fairly similar.407
The largest difference occurs in the Neuroblastoma data set. Here for the most extreme408
value that we allow for mstop, namely 200, the number of predictors is much lower409
for mboost (28) than for CoxBoost (53). Please note that the slopes of the curves are410
also strongly related to the value chosen for the penalty parameter. The stronger the411
penalty (i.e., smaller ν for mboost, larger λ for CoxBoost, see also De Bin 2016),412
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Fig. 3 Optimal number of steps plotted against the number of predictors included in the respective model,
for both CoxBoost (left) and mboost (right)
the less steep the curve. For mboost we used ν = 0.1 and for CoxBoost λ = 2052413
for the breast cancer data, λ = 1422 for the DLBCL data, λ = 1854 for the AML414
data and λ = 720 for the neuroblastoma data. These values were computed using the415
procedure described in Sect. 2.2. Larger values of the penalty parameter correspond416
to smaller step-wise updates of the coefficients, and consequently there are more417
iterations without adding new predictors (flat parts of the curves in Fig. 3); with a418
larger penalty it may be necessary to perform two boosting steps to obtain the same419
coefficient update obtained in one step in case of a small penalty.420
3.3.4 Prediction ability421
When we are interested in explanatory models, knowledge of the selected predictors422
and the stability of the resulting model among several repetitions of the same procedure423
is particularly important. This is not, however, the main focus of boosting: the boosting424
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approach is mainly used in the context of prediction models, where the focus is more425
on the goodness of the prediction than on the model itself. For example, if we have two426
strongly correlated predictors, from a predictive point of view it is equivalent to include427
the former, the latter, or both with two coefficients that combine their effects. For this428
reason, here we investigate the effect of the randomness of the cross-validation-based429
choice of mstop on the prediction ability, analyzing the differences in the estimates of430
the integrated Brier score among the resultant models. We report in the white boxplots431
of Fig. 4 the results for CoxBoost (left) and for mboost (right) using 3-, 5-, 10-, 20-432
fold and leave-one-out CV. The results are based on 2000 iterations, except for the433
leave-one-out CV, for which, obviously, only one value is provided.434
As a consequence of the decrease in the variability of mstop, and the relative decrease435
in the variability in terms of selected predictors, the variability of the integrated Brier436
score decreases with an increase in the number of cross-validation folds. We note a437
peculiar behavior in the acute myeloid leukemia example: despite it having the lowest438
variability in terms of mstop, it shows a high variability in terms of integrated Brier439
score, with several cases of extremely high values (visualized by the outlier-points in440
the box-plots of Fig. 4). Strongly unexpected, leave-one-out CV leads to good results441
for mboost on the breast cancer data set. For some unknown reasons in this case the442
more complex model is the better model. This does not happen often, and may be a443
particularity of this data set, in which predictors with weak effects are relevant. Note444
that this result may explain why in the original study a complex gene-signature (up to445
73 probe-sets) leads to good results, which have not been obtained when focusing on446
sparse models (see, e.g. De Bin et al. 2014b). Please note that, in general, the inclusion447
of more predictors decreases the model portability (the model is too specific for the448
learning data). In this sense, it is not surprising that this result has been obtained by449
using leave-one-out CV, which is known to favor data-specific models. In all other450
cases, indeed, the integrated Brier score from leave-one-out CV is higher than the451
median of the integrated Brier score from other folds, including CoxBoost on the452
breast cancer data set.453
Figure 5 shows the connection between the number of boosting steps and the inte-454
grated Brier score for all analyses. Again, note that given a certain mstop the model455
is deterministic and thus we do not differentiate between types of CV here. For the456
Breast cancer and the Neuroblastoma data sets the figures suggest that mstop greater457
than 200 should have been chosen, whereas for the other two data sets 200 was more458
than enough. The figure also gives information on why for the AML data set there are459
such outliers in the integrated Brier score seen in Fig. 4: The prediction performance460
is very bad if there are only very few boosting steps but improves quickly with an461
increase in the number of boosting steps.462
4 Effect of repeated cross-validation463
In the previous section we saw that the randomness of the folds split in the cross-464
validation procedure causes variation in the results and the prediction ability. From a465
theoretical point of view, to avoid this problem we should consider all the combinations466
of the n observations in K folds, following the theory of complete cross-validation467
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(Kohavi 1995), and transform the estimator of mstop based on the cross-validated468
likelihood into a complete U-statistic. With the usual sample size of a medical study,469
this is clearly computationally unfeasible (see also Fuchs et al. 2013). Between the470
current case of only one split and the theoretical case of all splits, nonetheless, there471
are several intermediate cases in which we can obtain a more stable result in an472
acceptable amount of time. For this reason, we suggest the use of a repeated cross-473
validation procedure for the choice of the tuning parameter: instead of considering the474
cross-validated partial log-likelihood, one should consider a repeated cross-validated475
partial log-likelihood,476
rcvpl(m) =
R∑
r=1
cvplr (m)477
with R being the number of repetitions and cvplr (m) the cross-validated partial478
log-likelihood of the r -th repetition. Note that due to the random nature of cross-479
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validation the subsets D1, . . . , DK (see Eq. 1) are different for each repetition480
r = 1, . . . , R.481
Again, the optimal value of mstop is computed by maximizing the function over m.482
4.1 Study design483
The repeated cross-validated likelihood should be based on the maximum feasible484
number of different splits, i.e. the largest I that is within the constraints of rea-485
sonable calculation time. In our study, involving 2000 replications of 4 kinds of486
cross-validation, we consider I = 10 as well as I = 50. Obviously, when the goal is to487
fit a prediction model based on a specific sample, a larger number can be considered.488
The data sets and the methods used in this section are the same as Sect. 3. Leave-one-489
out CV is not considered again because the results do not change. We fit a prediction490
model using the tuning parameter computed in a 3-, 5-, 10- and 20-fold CV procedure491
and we consider the selected predictors and the prediction ability in terms of integrated492
Brier score. The procedure is repeated 2000 times.493
4.2 Results494
In this section we focus on the impact of repeated CV and with this, also address the495
parts of the previous figures that were not addressed in Sect. 3.496
4.2.1 Number of boosting steps497
Figure 1 shows the improvements in stability in the choice of the optimal number of498
boosting steps using the repeated cross-validated partial log-likelihood. If we compare499
the results of repeated cross-validation in gray and normal cross-validation in white,500
we note a pronounced decrease in the variability, both in terms of interquartile and501
total range. The decrease between normal CV and the 10 times repeated CV is greater502
than the decrease between 10 and 50 repetitions. The medians of the distributions are503
almost equal with a light tendency of being lower when computed with the repeated504
cross-validated partial log-likelihood. The reason probably lies in the avoidance of505
the highest values that characterized the distributions in the original cross-validation506
procedure. The absence of the extreme values (especially those on the borders, namely507
0 and 200), in particular, is the most positive improvement obtained by implementing508
the repeated cross-validation, because it prevents situations in which mstop is chosen509
incorrectly due to a particularly unfortunate partition of the observations.510
4.2.2 Selected predictors511
The superiority of a more stable choice for the optimal number of boosting steps is512
clear when examining selected predictors (Figure 7 in the Supplementary Material).513
Avoiding underestimation and overestimation of mstop, indeed, leads to the identifica-514
tion of a clear group of relevant predictors always selected in our 2000 replications,515
and to the decrease of the rarely selected predictors. The latter property is particularly516
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evident in the acute myeloid leukemia example, in which the maximum number of517
selected predictors is 22 when using 10 repetitions and 19 with 50 repetitions. We note518
that with 50 repetitions we are relatively close to a deterministic result, i.e. the inclu-519
sion frequencies of the predictors is mostly 2000 (always) or 0 (never). The median520
number of predictors selected barely changes except for the Breast cancer data, for521
which the median number of predictors selected is lower when the cross-validation522
is repeated. The complete information on which predictors were selected is shown in523
Tables 2–13 in the Supplementary Material.524
4.2.3 Prediction ability525
The analysis of the integrated Brier score also reflects the advantages of using a526
repeated cross-validated partial log-likelihood for the choice of mstop. As can be seen527
in Fig. 4, the avoidance of extreme values for the tuning parameter results in the528
disappearance of the worst prediction performances obtained with the simple cross-529
validated partial log-likelihood. For the acute myeloid leukemia example for both530
mboost and CoxBoost the bad predictions experienced in the previous section do not531
occur. The improvement between 10 and 50 repetitions of cross-validation is not as532
striking as between none and 10 repetitions but with 50 repetitions we come even533
closer to a stable result, especially for 3-fold CV. To support our findings through534
Fig. 4 and to analyse the importance of both the number of folds in CV and the535
number of repetitions, we computed a linear model with the interquartile range of536
the integrated Brier score as endpoint including main effects of repeated CV and the537
number of folds. We computed the interquartile range from the 2000 iterations for538
each method (CoxBoost and mboost), data set, number of folds and number of CV539
repetitions, which results in 96 values. We computed a separate model for mboost and540
CoxBoost. The models show that using 10 repetitions instead of 1 has a significant541
impact whereas using 50 repetitions instead of 10 is not as pronounced for both mboost542
and CoxBoost (see Table 14 in the Supplementary Material). The more folds are used543
the lower the interquartile range of the integrated Brier score, but the only confidence544
interval where both limits are (at least slightly) negative is in the comparison of 5545
versus 3 folds. The effects estimated from the linear models depend strongly on the546
four data sets selected. However a simulation study showed comparable results (see547
Table 1 in the Supplementary Material) which further supports our findings.548
5 Conclusions549
Boosting techniques have proved to be useful tools in selecting a prediction model,550
especially in the important case in which the number of predictors is much higher than551
the number of observations. One weakness of boosting is the strong dependence on552
tuning parameter mstop, namely the number of boosting steps. Please note that several553
statistical methods share this weakness. Until now there has not been a convincing554
theory developed on the choice of this parameter and practitioners are compelled555
to use a cross-validation procedure. We have seen that this solution is sub-optimal,556
since it may lead to surprisingly different results in terms of selected predictors and557
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prediction ability of the model depending on the particular partition of the observations558
into the CV folds. A particularly unfortunate split may cause a severe underestimation559
or overestimation of the optimal value of boosting steps, with the consequence that560
the boosting algorithm may produce a very misleading model. We have seen that this561
problem affects the CV procedure irrespectively of the number of folds used. In our562
study, we showed that the implementation of a repeated CV procedure decreases the563
variability in the choice of the tuning parameter and produces a more robust result: as564
a consequence, far fewer extreme values of mstop would be expected. The results of the565
10-replication cross-validated partial log-likelihood suggest that few replications are566
sufficient to greatly improve the selection of the best tuning parameter. The extension to567
50 replications shows that increasing the number of replications may lead to even better568
results. As often happens, however, there is no free-lunch solution and an increase in569
replications also results in a large increase in the number of computations to perform.570
Therefore, the trade-off between variability reduction and computational time plays an571
important role in the choice of the number of replications. In our opinion, 10 (or only572
a few more, let us say 15 or 20) replications may be sufficient to avoid extreme cases573
and, consequently, obtain reliable results. Nevertheless, we note that the advances in574
computational techniques (e.g., parallel computing) and computational power (better575
hardware) constantly relax the computational time issues, and in the future more576
replications may be implemented without noticeable drawbacks. In this work we577
focused on boosting for high-dimensional linear Cox-models. We believe that repeated578
cross-validation will lead to similar improvements in other contexts. Details, however,579
have to be studied.580
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